bacitracin topical (OTC)

Brand and Other Names:Baciguent
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

ointment

  • 500unit/g

Dermal Infections (Superficial)

Apply ointment qDay-q8hr

Dosage Forms & Strengths

ointment

  • 500unit/g

Dermal Infections (Superficial)

Apply ointment qDay-q8hr

Next:

Adverse Effects

Frequency Not Defined

Rash

Itching

Pain

Hypersensitivity reaction (rare)

Previous
Next:

Warnings

Contraindications

Hypersensitivity, atopic patients

Cautions

Preparations should not be used for longer than 1 wk unless directed by a physician

Previous
Next:

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Excretion in milk unknown; use with caution

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Previous
Next:

Pharmacology

Mechanism of Action

Inhibits bacterial cell wall synthesis, by preventing the incorporation of mucopeptides into the growing cell wall

Absorption

Not substantially absorbed from intact or denuded skin, wounds, or mucous membranes

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.